Correlation Between Vigil Neuroscience and Century Therapeutics

Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vigil Neuroscience and Century Therapeutics, you can compare the effects of market volatilities on Vigil Neuroscience and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Century Therapeutics.

Diversification Opportunities for Vigil Neuroscience and Century Therapeutics

-0.03

Correlation Coefficient

Vigil Neuroscience  Century Therapeutics

Good diversification

The 3 months correlation between Vigil and Century is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Century Therapeutics go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Century Therapeutics

Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Century Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Vigil Neuroscience is 1.09 times less risky than Century Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Century Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  154.00  in Century Therapeutics on September 12, 2024 and sell it today you would lose (13.00) from holding Century Therapeutics or give up 8.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vigil Neuroscience  vs.  Century Therapeutics

Vigil Neuroscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Century Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Century Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Century Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Vigil Neuroscience and Century Therapeutics

The main advantage of trading using opposite Vigil Neuroscience and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.

The idea behind Vigil Neuroscience and Century Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.